AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011
May 17, 2011
30583_dirs_2011-05-17_3a396bd2-472b-47c7-917b-4efa3958d438.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-05-12
Reporting Person: BATE KENNETH (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-12 | Common Stock | A | 1875 | — | Acquired | 1875 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-12 | Stock Option (right to buy) | $26.49 | A | 11250 | Acquired | 2021-05-11 | Common Stock (11250) | Direct |
Footnotes
F1: Restricted stock units granted on May 12, 2011. Price not applicable.
F2: Options vest 1/4 each on August 12, 2011, November 12, 2011, February 12, 2012, and May 12, 2012.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19